Formycon AG (FYB) NPV
Sell:€53.10Buy:€53.30
No change
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:€53.10
Buy:€53.30
Change:No change
No changePrices delayed by at least 15 minutes
Sell:€53.10
Buy:€53.30
Change:No change
No changePrices delayed by at least 15 minutes
Company Information
About this company
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Key people
Olaf Stiller
Chairman of the Supervisory Board
Stefan Glombitza
Chief Executive Officer, Member of the Executive Board
Peter Wendeln
Deputy Chairman of the Supervisory Board
Enno Spillner
Chief Financial Officer, Member of the Executive Board
Andreas Seidl
Chief Scientific Officer, Member of the Executive Board
Nicola Mikulcik
Member of the Executive Board, Chief Business Officer
Wolfgang Essler
Member of the Supervisory Board
Klaus Roehrig
Member of the Supervisory Board
Click to see more
Key facts
- EPIC-
- LocationGermany
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINDE000A1EWVY8
- Market cap€918.55m
- Employees239
- Shares in issue17.66m
- ExchangeXETRA
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.